Price Alert

ImmunoPrecise Antibodies ... (IPA)

NASDAQ: IPA · Real-Time Price · USD

2.76

-0.44 (-13.75%)

At close: Aug 25, 2025, 3:59 PM

2.94

6.52%

Pre-market: Aug 26, 2025, 09:00 AM EDT

ImmunoPrecise Antibodies Cash Flow Statement

Financials in CAD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021
Net Income	-30.23M	-27.18M	-26.56M	-16.71M	-7.34M
Depreciation & Amortization	5.12M	5.74M	6.68M	3.77M	3.71M
Stock-Based Compensation	445K	1.53M	1.94M	3.08M	2.75M
Other Working Capital	794K	3.07M	-976K	139K	-190K
Other Non-Cash Items	21.81M	15.06M	2.3M	-310K	1.38M
Deferred Income Tax	-3.94M	-1.77M	-926K	-336K	-83K
Change in Working Capital	386K	2.37M	-3.28M	582K	-1.02M
Operating Cash Flow	-6.41M	-4.25M	-19.83M	-9.92M	-600K
Capital Expenditures	-799K	-1.4M	-1.5M	-1.26M	-1.43M
Cash Acquisitions	n/a	-146K	-592K	-3.69M	-1.03M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	121K	80K	n/a	n/a
Other Investing Acitivies	n/a	-141K	40K	-259K	n/a
Investing Cash Flow	-799K	-1.56M	-1.97M	-5.21M	-2.46M
Debt Repayment	2.67M	-1.34M	-1.34M	-962K	-772K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	2.36M	n/a	-5K	n/a
Financial Cash Flow	14.89M	1.02M	-621K	2.88M	43.38M
Net Cash Flow	7.25M	-4.82M	-21.68M	-11.79M	39.15M
Free Cash Flow	-7.21M	-5.64M	-21.33M	-11.18M	-2.03M